Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas.

Iliuta, Ioan-Andrei

Reversal of Severe and Refractory Humoral Hypercalcemia With 177Lu-Octreotate Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumor of the Pancreas. [electronic resource] - Clinical nuclear medicine Sep 2015 - e448-50 p. digital

Publication Type: Case Reports; Journal Article

1536-0229

10.1097/RLU.0000000000000862 doi


Humans
Hypercalcemia--etiology
Male
Middle Aged
Neuroendocrine Tumors--complications
Octreotide--analogs & derivatives
Pancreatic Neoplasms--complications
Radiopharmaceuticals--therapeutic use